Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis
Andreas Karwath(Cancer Research UK Clinical Trials Unit), Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Alastair Mobley(University Hospitals Birmingham NHS Foundation Trust), Otilia Țica, Marcus Flather(Royal Brompton Hospital), Samantha C. Pendleton(University of Birmingham), Andrew J.S. Coats(IRCCS Ospedale San Raffaele), Andrey Barsky(Cancer Research UK Clinical Trials Unit), John A. Williams(Cancer Research UK Clinical Trials Unit), Furqan Aziz(Cancer Research UK Clinical Trials Unit), Victor Roth Cardoso(University of Birmingham), Saisakul Chernbumroong(University of Birmingham), Jinming Duan(MRC London Institute of Medical Sciences), Simrat Gill(University Hospitals Birmingham NHS Foundation Trust), Georgios V. Gkoutos(University of Cambridge), Xiaoxia Wang(Peking University), Emma-Jane Bruce(University Hospitals Birmingham NHS Foundation Trust), Karina V Bunting
Cited by 100
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k